Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Processa Pharmaceuticals Inc PCSA

Healthcare Biotechnology
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s pipeline... see more

Current News (NDAQ:PCSA)

Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025

GlobeNewswire November 5, 2025

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

GlobeNewswire August 7, 2025

Processa Pharmaceuticals Provides Portfolio and Business Update

GlobeNewswire July 1, 2025

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

GlobeNewswire June 17, 2025

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

GlobeNewswire June 17, 2025

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

GlobeNewswire June 13, 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

GlobeNewswire May 30, 2025

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

GlobeNewswire April 15, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

GlobeNewswire March 18, 2025
View More News ››

Opinion & Analysis (NDAQ:PCSA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PCSA)

PCSA....N.H.o.D.....$0.3298

Watchout world
Iseneschal - June 20, 2025

PCSA....looking at the chart & seeing todays volume & ....

Price action.....sure does look like a break of 35 would be very meaningful....gotta get there 1st ; ) Volume & Price action is...
Iseneschal - June 20, 2025

PCSA...seriously?

I tried to buy this at 25 and missed it LoL....now it's 32 Sheesh !
Iseneschal - June 20, 2025

PCSA....go chit in a river

No Likey
Iseneschal - June 20, 2025

PCSA....N.L.O.D 23 pesos

Don't quit ur day job just yet
Iseneschal - June 17, 2025

PCSA.... it never fails to amaze me

How this can happen. The big pump right before the P.O announcement It's halted just to let The Greater Fools now...ur all Facked ;...
Iseneschal - June 17, 2025
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »